VF
IMVT icon

Virtu Financial’s Immunovant IMVT Stock Holding History

Virtu Financial’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-14,691
Closed -$564K – 1767
2023
Q3 		$564K Buy
14,691
+4,230
+40% +$95.6K 0.06% 305
2023
Q2 		$198K Buy
+10,461
New +$195K 0.02% 818
2022
Q2 		– Sell
-21,250
Closed -$117K – 1798
2022
Q1 		$117K Buy
21,250
+6,336
+42% +$39.5K 0.01% 933
2021
Q4 		$127K Buy
+14,914
New +$123K 0.01% 1024
2021
Q1 		– Sell
-6,385
Closed -$295K – 1801
2020
Q4 		$295K Buy
+6,385
New +$295K 0.03% 647

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Virtu Financial's IMVT Position: Q4 2023 in Review

Virtu Financial sold out of Immunovant (IMVT) in Q4 2023, closing a stake of 14,691 shares — an estimated $564K sold.

Virtu Financial first reported a position in IMVT in Q4 2020 and held it in 5 quarters. The position peaked at $564K in Q3 2023. 228 funds tracked by Wall St. Rank hold IMVT as of Q4 2023.

  • Virtu Financial reported no remaining Immunovant position as of Q4 2023 after selling out during the quarter.
  • Virtu Financial sold 14,691 Immunovant shares in Q4 2023, an estimated $564K.
  • Virtu Financial first reported a position in Immunovant in Q4 2020 and held it in 5 quarters.
  • Virtu Financial's Immunovant position peaked at $564K in Q3 2023.
  • 228 funds tracked by Wall St. Rank held Immunovant as of Q4 2023.

Based on Virtu Financial's 13F filing for Q4 2023, filed 26 Feb 2024.